Clara Health
Total Raised
$10.59MInvestors Count
16Deal Terms
2Funding, Valuation & Revenue
10 Fundings
Clara Health has raised $10.59M over 10 rounds.
Clara Health's latest funding round was a Acquired for on March 9, 2022.
Clara Health's valuation in February 2018 was $10M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/9/2022 | Acquired | 1 | ||||
1/17/2020 | Series A | $7.09M | Undisclosed Investors | 1 | ||
9/26/2019 | Incubator/Accelerator | 1 | ||||
2/20/2018 | Seed VC - III | $10M | ||||
6/16/2017 | Grant |
Date | 3/9/2022 | 1/17/2020 | 9/26/2019 | 2/20/2018 | 6/16/2017 |
|---|---|---|---|---|---|
Round | Acquired | Series A | Incubator/Accelerator | Seed VC - III | Grant |
Amount | $7.09M | ||||
Investors | Undisclosed Investors | ||||
Valuation | $10M | ||||
Revenue | |||||
Sources | 1 | 1 | 1 |
Clara Health Deal Terms
2 Deal Terms
Clara Health's deal structure is available for 2 funding rounds, including their Seed VC - III from February 20, 2018.
Round | Seed VC - III | Pre-Seed |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Seed VC - III | |||||||||||||||
Pre-Seed |
Clara Health Investors
16 Investors
Clara Health has 16 investors. M&B Sciences invested in Clara Health's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
3/9/2022 | 3/9/2022 | 1 Acquired | Corporation | California | ||
9/26/2019 | 9/26/2019 | 1 Incubator/Accelerator | Incubator/Accelerator | |||
12/15/2016 | 2/20/2018 | 2 Pre-Seed, Seed VC - III (2018) | Angel Investor (Individual) | United States | ||
Venture Capital | California | |||||
Venture Capital | California |
First funding | 3/9/2022 | 9/26/2019 | 12/15/2016 | ||
|---|---|---|---|---|---|
Last Funding | 3/9/2022 | 9/26/2019 | 2/20/2018 | ||
Investor | |||||
Rounds | 1 Acquired | 1 Incubator/Accelerator | 2 Pre-Seed, Seed VC - III (2018) | ||
Board Seats | |||||
Type | Corporation | Incubator/Accelerator | Angel Investor (Individual) | Venture Capital | Venture Capital |
Location | California | United States | California | California |
Compare Clara Health to Competitors
Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.
Science 37 operates within the life sciences sector, providing solutions for patient access to clinical trials. The company's services aim to assist life sciences companies in conducting clinical research through various methods. It was founded in 2014 and is based in Morrisville, North Carolina. In March 2024, Science 37 was acquired by eMed at a valuation of $38M.
Massive Bio operates as an artificial intelligence (AI) driven platform specializing in personalized oncology solutions within the healthcare sector. The company offers services connecting cancer patients and oncologists to clinical trials for new, alternative, and targeted treatments, as well as providing personalized treatment recommendations through a virtual tumor board. It primarily serves the healthcare industry, particularly oncology care providers and cancer patients seeking treatment options. It was founded in 2014 and is based in Istanbul, Turkey.
Curebase provides eClinical software for the clinical trials sector. The company offers tools for clinical trial processes, including electronic patient-reported outcomes (ePRO), electronic consent (eConsent), and electronic data capture (EDC) systems. It was founded in 2017 and is based in San Francisco, California.
Ask Aletta provides artificial intelligence (AI)-driven medical information services within the healthcare sector. The company offers an AI search engine that provides medical information to healthcare professionals, sourced from medical guidelines and accompanied by citations. Ask Aletta's services cater to various medical disciplines, offering responses based on different medical roles. It was founded in 2024 and is based in Amsterdam, Netherlands.
Antidote is involved in clinical trial patient recruitment within the healthcare and medical research sectors. The company provides recruitment services to assist clinical trial sponsors in filling trials and has a Match search engine to help patients find appropriate clinical trials. Antidote serves the healthcare industry with a focus on connecting patients to medical research opportunities. Antidote was formerly known as TrialReach. It was founded in 2010 and is based in North Miami Beach, Florida.
Loading...